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Abstract
Quantitative trait locus (QTL) mapping using deep DNA sequencing data is a challenging task. In this study we
performed region-based and pathway-based QTL mappings using a p-value combination method to analyze the
simulated quantitative traits Q1 and Q4 and the exome sequencing data. The aims were to evaluate the
performance of the QTL mapping approaches that were used and to suggest plausible strategies for QTL mapping
of DNA sequencing data. We conducted single-locus QTL mappings using a linear regression model with
adjustments for age and smoking status, and we also conducted region-based and pathway-based QTL mappings
using a truncated product method for combining p-values from the single-locus QTL mapping. To account for the
features of rare variants and common single-nucleotide polymorphisms (SNPs), we considered independently rare-
variant-only, common-SNP-only, and combined analyses. An analysis of 200 simulated replications showed that the
three region-based methods reasonably controlled type I error, whereas the combined analysis yielded the greatest
statistical power. Rare-variant-only, common-SNP-only, and combined analyses were also applied to pathway-based
QTL mappings. We found that pathway-based QTL mappings had a power of approximately 100% when the
significance of the vascular endothelial growth factor pathway was evaluated, but type I errors were slightly
inflated. Our approach complements single-locus QTL mapping. An integrated approach using single-locus,
combined region-based, and combined pathway-based analyses should yield promising results for QTL mapping of
DNA sequencing data.
Background
Deep DNA sequencing technology provides not only a
vast number of common single-nucleotide polymorph-
isms (SNPs) but also a vast number of rare variants for
genetic and genomic research. Mapping a quantitative
trait locus (QTL) using this kind of genomic data
remains a challenging task. p-Value combination meth-
ods have been used in genetic association studies in
which common SNPs were analyzed, but rare variants
were excluded from those studies [1-6]. To the best of
our knowledge, no previous studies have used p-value
combination methods to analyze rare variants. When
the p-value combination methods are applied to QTL
mapping of deep DNA sequencing data, the perfor-
mance of the methods and the plausible analytical
strategies for dealing with common SNPs and rare
variants remain unclear.
In this study we conduct region-based and pathway-
based QTL mappings using a p-value combination
method to identify genetic loci, regions, and pathways
responsible for a quantitative trait using exome DNA
sequencing data provided by Genetic Analysis Work-
shop 17 (GAW17). We propose and evaluate several
analytical strategies for QTL mapping of common SNPs
and rare variants in deep DNA sequencing data. In con-
trast to single-locus QTL mapping, region-based and
pathway-based QTL mappings using a p-value combina-
tion method are multilocus methods that have the fol-
lowing merits [4-6]: (1) The biological knowledge of
genes and pathways is incorporated; (2) the results are
linked directly to biological function; (3) the multilocus
methods may have greater statistical power; (4) the pro-
blem of multiple testing is reduced because fewer tests * Correspondence: hsinchou@stat.sinica.edu.tw
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mitigated because a group of loci are considered jointly.
The aims of this study are to evaluate the type I error
and statistical power associated with the proposed analy-
tical strategies for region-based and pathway-based QTL
mappings and to suggest plausible analytical strategies
for QTL mapping of deep DNA sequencing data.
Methods
Materials
GAW17 provided a mini-exome DNA sequencing data
set and 200 simulated data sets for a quantitative trait
for 697 unrelated individuals. The 1000 Genomes Pro-
ject donated genotype data composed of the DNA
sequences of 3,205 genes, containing 24,487 autosomal
common SNPs and rare variants [7]. More than 50% of
t h ev a r i a n t sw e r er a r ea n dh a dam i n o ra l l e l ef r e q u e n c y
(MAF) less than 0.01. Missing genotype data were
imputed. Data were obtained on the age, sex, and smok-
ing status for all subjects. Quantitative trait data were
generated as normally distributed phenotypes.
While evaluating the statistical power of the QTL
mapping approaches, we conducted QTL mappings
using the simulated quantitative trait Q1, which was
generated from a standard normal distribution with a
residual heritability of 0.44. This trait was designed to
be influenced by nine Q1-associated genes (ELAVL4,
ARNT, KDR, VEGFC, FLT4, VEGFA, FLT1, HIF1A,a n d
HIF3A), which function primarily in the vascular
endothelial growth factor (VEGF) pathway. The 9 genes
contained 125 SNPs, with 39 nonsynonymous common
SNPs or rare variants (MAFs ranging from 0.07% to
16.5%) designed to additively influence Q1. The total
effect sizes of the nonsynonymous variants within the
nine genes ranged from 0.59 to 5.7.
In order to evaluate type I error associated with the
QTL mapping approaches, we examined the association
between the nine Q1-associated genes and the simulated
quantitative trait Q4. Q4 was generated from a standard
normal distribution and had a heritability of 0.70. This
trait was designed to be uninfluenced by any of the gen-
otyped exonic common SNPs and rare variants.
Statistical methods
We analyzed 200 simulation replications. In each repli-
cation, we conducted single-locus QTL mappings using
a linear regression model in which the quantitative trait
(Q1 for the analysis of statistical power and Q4 for the
analysis of type I error) was the dependent variable and
genotype, age, and smoking status were independent
variables. The analyses were performed using PLINK
software [8]. The genotype was coded by using an addi-
tive effect random variable with values of 0, 1, or 2 for
genotypes AA, AB,o rBB, respectively, where A was the
major allele. Tests for normality showed that Q1
followed a standard normal distribution, but Q4 violated
a standard normal distribution in a large proportion of
the simulation replications. Therefore, for each simula-
tion replication, 1 million permutations were made and
used to calculate an empirical p-value for a single-locus
QTL mapping of Q4.
The methods that we used for our region-based and
pathway-based QTL mappings were as follows. To
account for the features of rare variants and common
SNPs, we divided genetic markers into two categories:
rare variants (MAF < 0.01) and common SNPs (MAF ≥
0.01). The region-based and pathway-based QTL map-
pings combined p-values from single-locus association
tests for rare variants and/or common SNPs in a region
or pathway. Several analytical strategies were considered:
(1) a rare-variant-only analysis, (2) a common-SNP-only
analysis, and (3) a combined analysis that integrated two
test statistics from a rare-variant-only analysis and a
common-SNP-only analysis. The test statistics are pro-
vided in what follows.
We assume that there are R rare variants and C com-
mon SNPs in a region or a pathway and that N = R + C.
We let {prare,r, r =1 ,…, R}a n d{ pcommon,c, c =1 ,…, C}
denote the p-values of single-locus association tests of R
rare variants and C common SNPs, respectively. In the
rare-variant-only analysis, p-values for only rare variants
were combined to calculate a truncated product p-value
statistic (TPPS) [1-3]:
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where I[·] denotes an indicator function and constant
θ denotes the truncation threshold of p-values. Similarly,
in the common-SNP-only analysis, p-values for only
common SNPs were combined to calculate a TPPS:
Zp c
Ip
cC
c
common common
common =
<
≤≤ ∏ () . ,
[] , q
1
(2)
In the combined analysis, p-values for all genetic mar-
kers were merged to calculate a combined TPPS:
ZZ Z combined common rare =× . (3)
In this study, the truncation threshold of p-values was
set at 0.05, and the empirical p-values of the TPPSs
were obtained using a Monte Carlo procedure with
10,000 replications (refer to the “Correlated Tests” sec-
tion in Zaykin et al. [1]). The problem of multiple test-
ing was controlled by using false discovery rates (FDRs)
[9], and FDR-corrected p-values were calculated
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was declared if the FDR-corrected p-value was less than
0.05. In this study, a QTL could be a SNP mapped by a
single-locus association test, a well-defined genomic
region mapped by a region-based association test, or a
biological pathway identified by a pathway-based asso-
ciation test. All the region- and pathway-based QTL
mappings were conducted using software that we devel-
oped: Omnibus p-value Association Tests (OPATs).
In the region-based QTL mapping, the unit of a
region could be a gene, an exonic region, or another
predefined region. The unit used in this study was a
gene region. Our pathway-based QTL mappings focused
on the VEGF pathway because the nine Q1-associated
genes were from this pathway. We evaluated power and
type I error for single-locus, region-based, and pathway-
based QTL mappings. The power of the QTL mappings
was calculated as the proportion of times that an asso-
ciation test for trait Q1 accurately identified the true
QTL of Q1 in 200 simulation replicates. The type I
error for a QTL mapping was calculated as the propor-
tion of times that a QTL mapping for trait Q4 identified
the spurious QTL of Q4 in 200 simulation replicates.
Note that simulation replications were removed from
the power and type I error calculations if only one p-
value remained after applying a p-value truncation.
When we compared the power of single-locus and
region-based QTL mappings, the comparisons were
made within the same unit of a genomic segment; in
other words, the genomic region was declared to be a
QTL in a single-locus QTL mapping if any Q1-asso-
ciated rare variants or common SNPs were found within
that region.
Results
Our analyses were performed with knowledge of the
underlying simulation model. Power and type I error for
the single-locus and the three region-based QTL map-
pings for identification of the nine Q1-associated genes
are shown in Figure 1. In general, for both single-locus
and region-based QTL mappings, type I error was con-
trolled under the prespecified nominal significance level
of 0.05 for the nine Q1-associated genes. Power to
detect the nine Q1-associated genes varied by the
method of QTL mapping and the genes studied, reflect-
ing the discrepancy in the effect sizes and the frequen-
cies of rare variants and common SNPs within each of
the nine Q1-associated genes in the simulation data set.
KDR and FLT1, which were the top two genes in terms
of total effect size, were successfully identified by all
methods. ELAVL4, ARNT,a n dHIF1A were identified
primarily by the analyses that used common SNP infor-
mation. In contrast, VEGFC and VEGFA were identified
primarily by the analyses that used rare variant
information; VEGFC did not contain any common
SNPs. The power to identify FLT4 came primarily from
the combined information provided by both common
SNPs and rare variants. HIF3A was the most difficult
gene to identify.
In a comparison of region-based and single-locus QTL
mappings, the region-based QTL mappings often had
greater power than the single-locus QTL mappings. The
only counterexamples were the following: The single-
locus analysis was more powerful than the combined
analysis in identifying ARNT (a difference in power of
9%) and HIF3A (a difference in power of 8.2%) (Figure
1A); and the single-locus analysis was more powerful
than the rare-variant-only analysis in identifying FLT1 (a
difference in power of 5%) (Figure 1B). These results
can be explained by the fact that ARNT and FLT1 con-
tain several markers that have highly significant p-
values. In a comparison of the three region-based ana-
lyses, the combined analysis generally performed better
than the other two region-based analyses (Figure 1A).
The rare-variant-only analysis showed very low power in
detecting ELAVL4 (2%), ARNT (2.3%), HIF1A (9.3%),
and HIF3A (5.4%) (Figure 1B), and the common-SNP-
only analysis showed very low power in detecting
VEGFC (0%) and VEGFA (4.6%); VEGFC did not con-
tain any common SNPs (Figure 1C). The integration of
the results from the single-locus QTL mapping and the
combined analysis results from the region-based QTL
mapping provided competitive power and reasonable
type I error compared with the results from the other
QTL mappings. Similar results were also found when
we conducted QTL mappings without a covariate
adjustment or with an adjustment for age or smoking
status alone (data not shown).
Pathway-based QTL mappings were evaluated by
examining the power related to the detection of an asso-
ciation between Q1 and the VEGF pathway and by
examining the type I error related to the detection of an
association between Q4 and the VEGF pathway. We
conducted the combined, rare-variant-only, and com-
mon-SNP-only analyses. The results showed that the
power for the three analyses was close to 100% and that
the type I error for the combined, rare-variant-only, and
common-SNP-only analyses was 6.1%, 8.2%, and 5.8%,
respectively. Pathways other than the VEGF pathway
were not analyzed because we did not know whether or
not they were associated with Q1.
We applied region-based QTL mappings to analyze all
24,487 common SNPs and rare variants within 3,205
genes for the first replication of 200 simulations. The
analysis was finished within half an hour using a perso-
nal computer with an Intel E8400 CPU and two DDR2-
800 2GB RAMs. Among the nine Q1-associated genes,
the single-locus QTL mapping identified four Q1-
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Page 3 of 5Figure 1 Power and type I error for single-locus and region-based QTL mappings.P o w e ra n dt y p eIe r r o rf o rt h r e er e g i o n - b a s e dQ T L
mappings: (A) combined analysis; (B) rare-variant-only analysis; and (C) common-SNP-only analysis. In each panel, the results of the single-locus
QTL mapping are also provided for comparison. Red bars indicate that a QTL is identified by both single-locus and region-based QTL mappings.
Blue hatched bars indicate that a QTL is identified only by the single-locus but not the region-based QTL mapping. Green hatched bars indicate
that a QTL is identified only by the region-based but not the single-locus QTL mapping.
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HIF1A. The combined region-based analysis also identi-
fied KDR, VEGFC, FLT1,a n dHIF1A as well as two Q1-
associated genes, ELAVL4 and VEGFA.
Discussion and conclusions
Region-based QTL mapping using a truncation product
p-value method provides an alternative to single-locus
QTL mapping. In comparison with single-locus QTL
mapping, region-based QTL mapping has several
strengths [4-6], as discussed in the Background section.
We recommend using region-based QTL mapping with
p-value combination unless the study region contains
markers with strong marginal effects. Single-locus map-
ping is powerful enough to identify a QTL with a strong
marginal effect. Among the three proposed region-based
analyses, a combined analysis that uses information
from both common SNPs and rare variants provides
greater power than a rare-variant-only analysis or a
common-SNP-only analysis. In a combined analysis, an
alternative to the combined test statistic used in this
study is the minimum test statistic of the rare-variant-
only and common-SNP-only TPPS. However, our simu-
lation results show that the multiplication test statistic is
more powerful than the minimum test statistic (data not
shown).
We suggest an integrated analysis of the single-locus
method and the combined region-based method for
QTL mapping of deep DNA sequencing data; this strat-
egy provides a powerful way to identify QTLs with a
well-controlled type I error. In addition, this procedure
can be extended to examine the biological pathways or
biological processes involved in complex disease. Com-
bined pathway-based QTL mapping with the TPPS pro-
vides high power in the detection of associations
between the VEGF pathway and Q1 and reasonable type
I error in the detection of associations between the
VEGF pathway and Q4.
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